Evaluation of LDL Cholesterol in Patients Switched From 10 to 5 Milligrams of Zetia (Ezetimibe)
Status:
Completed
Trial end date:
2008-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the effect on LDL cholesterol levels of converting
patients who are receiving the cholesterol absorption inhibitor Zetia at a dose of 10
milligrams to 5 milligrams, when prescribed as a split 10 milligram tablet.